News Releases

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
    • Filter by program
    About Ludwig Cancer genomics Cancer prevention Tumor biology Tumor immunology Tumor microenvironment
    View All
    Novel blood test for predicting response to cancer therapy to be commercialized by Ludwig start-up Serametrix Corporation
    December 9, 2013
    Cancer’s game of hide-and-seek
    December 5, 2013
    Cancer mutation likely trigger of scleroderma
    December 5, 2013
    Ludwig Scientist Bing Ren elected Fellow of the American Association for the Advancement of Science
    November 25, 2013
    New therapeutic target identified for ALS and frontotemporal degeneration
    November 11, 2013
    CureVac collaborates with the Cancer Research Institute and Ludwig Cancer Research to enable clinical testing of novel immunotherapy treatment options for cancer
    November 5, 2013
    Is DNA from mom or dad?
    November 5, 2013
    Targeting cancer’s sweet tooth
    October 21, 2013
    Ludwig Scientist Richard D. Kolodner elected to the Institute of Medicine
    October 21, 2013
    A genetic variation that could protect skin from sun damage fuels testicular cancer
    October 10, 2013
    A boost for cellular profiling
    September 22, 2013
    Epigenetic memory
    September 4, 2013
    Ludwig scientists at Johns Hopkins find promising therapeutic target for hard-to-treat brain tumor
    August 27, 2013
    ʻDark-horseʼ molecule is a potential new anti-cancer target
    August 12, 2013
    New insights into neuroblastoma tumor suppressor may provide clues for improved treatment
    August 12, 2013
    Genome sequencing proves herbal remedy causes upper urinary tract cancers
    August 7, 2013
    Ludwig scientists at Stanford University unable to find evidence of “embryonic-like” cells in marrow of adult mice
    July 24, 2013
    Ludwig and Nature to host nuclear reprogramming conference, September 25-27 at University of Oxford
    July 1, 2013
    Researchers report a therapeutic strategy that appears to destroy drug resistant melanomas and suppress metastasis
    June 20, 2013
    Immune Design partners with leading cancer organizations to advance novel immunotherapy research
    June 12, 2013
    Concurrent treatment with two antibodies that boost the immune response to tumors in distinct ways appears to be highly effective against metastatic melanoma
    June 2, 2013
    Anti-CD47 antibody may offer new route to a successful cancer vaccination
    May 31, 2013
    Oncogene mutation hijacks splicing process to promote growth and survival
    May 31, 2013
    Engineered molecules boost immune attack on cancer
    May 31, 2013
    Professor Sir David Lane named scientific director of the Ludwig Institute for Cancer Research
    May 30, 2013
    Researchers elucidate how precise chemical modifications across the genome turn genes on and off during early human development—and how those mechanisms are disrupted in cancer
    May 9, 2013
    New research reveals how the tumor suppressor p53 is shut down in metastatic melanoma—and how it can be revived
    April 25, 2013
    A check on tension—Ludwig discovery upends model for cell division
    April 22, 2013
    Ludwig Uppsala Director Carl-Henrik Heldin new chairman of the Nobel Foundation
    April 11, 2013
    Ludwig presents advancements in immunotherapy and epigenetics at AACR meeting
    April 10, 2013
    Researchers describe for the first time how certain brain tumors adapt to exploit normal cellular signaling pathways to develop drug resistance
    April 8, 2013
    Screening blood samples for cancer-driving mutations more comprehensive than analyzing traditional biopsy
    April 8, 2013
    Ludwig cancer researchers honored among first class of fellows in AACR Academy
    March 26, 2013
    Novel combination therapy shuts down escape route, killing glioblastoma tumor cells
    February 26, 2013
    Ludwig oncologist Vogelstein at Johns Hopkins receives $3 million life sciences award
    February 22, 2013
    Pathway controlling cell growth revealed
    February 18, 2013
    Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests, Stanford researchers say
    February 5, 2013
    An analysis of how the epigenetic marker 5-hydroxymethylcytosine is interpreted by neural cells opens the door to studying its role in developmental disorders and disease
    February 4, 2013
    4-Antibody AG and the Ludwig Institute expand oncology antibody R&D program with three new
    January 29, 2013
    Potential new treatment for gastrointestinal cancers discovered
    January 16, 2013
    Ludwig scientists at Johns Hopkins use pap test fluid to detect ovarian, endometrial cancers
    January 9, 2013
       Back to News

    Stay In Touch

    Notice
    ?

    You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

    Continue
    Cancel